Search Results - "Scaria, Anish"

A digital health intervention for cardiovascular disease management in primary care (CONNECT) randomized controlled trial by Redfern, Julie, Coorey, Genevieve, Mulley, John, Scaria, Anish, Neubeck, Lis, Hafiz, Nashid, Pitt, Chris, Weir, Kristie, Forbes, Joanna, Parker, Sharon, Bampi, Fiona, Coenen, Alison, Enright, Gemma, Wong, Annette, Nguyen, Theresa, Harris, Mark, Zwar, Nick, Chow, Clara K., Rodgers, Anthony, Heeley, Emma, Panaretto, Katie, Lau, Annie, Hayman, Noel, Usherwood, Tim, Peiris, David

“…Digital health applications (apps) have the potential to improve health behaviors and outcomes. We aimed to examine the effectiveness of a consumer web-based…”
Get full text

Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): a randomised trial by Johnson, David W, Prof, Badve, Sunil V, MD, Pascoe, Elaine M, MBiostat, Beller, Elaine, MAppStat, Cass, Alan, Prof, Clark, Carolyn, MBChB, de Zoysa, Janak, MBChB, Isbel, Nicole M, PhD, McTaggart, Steven, PhD, Morrish, Alicia T, MPH, Playford, E Geoffrey, PhD, Scaria, Anish, MSc, Snelling, Paul, MBChB, Vergara, Liza A, PhD, Hawley, Carmel M, MMedSci

“…Summary Background There is a paucity of evidence to guide the best strategy for prevention of peritoneal-dialysis-related infections. Antibacterial honey has…”
Get full text

Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and Canada by Ha, Jeffrey T., Scaria, Anish, Andrade, Jason, Badve, Sunil V., Birks, Peter, Bota, Sarah E., Campain, Anna, Djurdjev, Ognjenka, Garg, Amit X., Harel, Ziv, Hemmelgarn, Brenda, Hockham, Carinna, James, Matthew T., Jardine, Meg J., Lam, Dickson, Levin, Adeera, McArthur, Eric, Ravani, Pietro, Shao, Selena, Sood, Manish M., Tan, Zhi, Tangri, Navdeep, Whitlock, Reid, Gallagher, Martin, Jun, Min

“…The benefit–risk profile of rivaroxaban versus warfarin for atrial fibrillation (AF) in patients with chronic kidney disease is uncertain. We compared…”
Get full text

Effect of extended hours dialysis on markers of chronic kidney disease-mineral and bone disorder in the ACTIVE Dialysis study by Zhan, Zhipeng, Smyth, Brendan, Toussaint, Nigel D, Gray, Nicholas A, Zuo, Li, de Zoysa, Janak R, Chan, Christopher T, Jin, Chenggang, Scaria, Anish, Hawley, Carmel M, Perkovic, Vlado, Jardine, Meg J, Zhang, Ling

“…Chronic Kidney Disease - Mineral and Bone Disorder (CKD-MBD) is a significant cause of morbidity among haemodialysis patients and is associated with…”
Get full text

The HONEYPOT Randomized Controlled Trial Statistical Analysis Plan by Pascoe, Elaine Mary, Lo, Serigne, Scaria, Anish, Badve, Sunil V, Beller, Elaine Mary, Cass, Alan, Hawley, Carmel Mary, Johnson, David W

“…The HONEYPOT study is a multicenter, open-label, blinded-outcome, randomized controlled trial designed to determine whether, compared with standard topical…”
Get full text

Association between Serum Alkaline Phosphatase and Primary Resistance to Erythropoiesis Stimulating Agents in Chronic Kidney Disease: A Secondary Analysis of the HERO Trial by Badve, Sunil V., Zhang, Lei, Coombes, Jeff S., Pascoe, Elaine M., Cass, Alan, Clarke, Philip, Ferrari, Paolo, McDonald, Stephen P., Morrish, Alicia T., Pedagogos, Eugenie, Perkovic, Vlado, Reidlinger, Donna, Scaria, Anish, Walker, Rowan, Vergara, Liza A., Hawley, Carmel M., Johnson, David W.

“…Background: Erythropoiesis stimulating agent (ESA)-resistant anemia is common in chronic kidney disease (CKD). Objectives: To evaluate the determinants of…”
Get full text

An Internet-Based Intervention for Cardiovascular Disease Management Integrated With Primary Care Electronic Health Records: Mixed Methods Evaluation of Implementation Fidelity and User Engagement by Coorey, Genevieve, Peiris, David, Scaria, Anish, Mulley, John, Neubeck, Lis, Hafiz, Nashid, Redfern, Julie

“…Growing evidence supports the benefits of eHealth interventions to increase patient engagement and improve outcomes for a range of conditions. However,…”
Get full text

Patient factors associated with dermatology outpatient non-attendance: An analysis of racial and ethnic diversity by Doolan, Brent J., Saikal, Samra L., Scaria, Anish, Gupta, Monisha

“…Non-attendance to dermatology outpatient appointments is a risk factor for poorer patient outcomes. The culturally and linguistically diverse (CALD)…”
Get full text

Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial by Loo, Colleen, Glozier, Nick, Barton, David, Baune, Bernhard T., Mills, Natalie T., Fitzgerald, Paul, Glue, Paul, Sarma, Shanthi, Galvez-Ortiz, Veronica, Hadzi-Pavlovic, Dusan, Alonzo, Angelo, Dong, Vanessa, Martin, Donel, Nikolin, Stevan, Mitchell, Philip B., Berk, Michael, Carter, Gregory, Hackett, Maree, Leyden, John, Hood, Sean, Somogyi, Andrew A., Lapidus, Kyle, Stratton, Elizabeth, Gainsford, Kirsten, Garg, Deepak, Thornton, Nicollette L. R., Fourrier, Célia, Richardson, Karyn, Rozakis, Demi, Scaria, Anish, Mihalopoulos, Cathrine, Chatterton, Mary Lou, McDonald, William M., Boyce, Philip, Holtzheimer, Paul E., Kozel, F. Andrew, Riva-Posse, Patricio, Rodgers, Anthony

“…Prior trials suggest that intravenous racemic ketamine is a highly effective for treatment-resistant depression (TRD), but phase 3 trials of racemic ketamine…”
Get full text

The Effect of Low Dose Corticosteroids and Theophylline on the Risk of Acute Exacerbations of COPD. The TASCS Randomised Controlled Trial by Jenkins, Christine R, Wen, Fu-Qiang, Martin, Allison, Barnes, Peter J, Celli, Bartolome, Zhong, Nan-Shan, Zheng, Jin-Ping, Scaria, Anish, Di Tanna, Gian-Luca, Bradbury, Thomas, Berend, Norbert

“…The highest burden of Chronic Obstructive Pulmonary Disease (COPD) occurs in low and middle income countries. Low cost oral medications, if effective, could…”
Get full text

Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial - CORRIGENDUM by Loo, Colleen, Glozier, Nick, Barton, David, Baune, Bernhard T, Mills, Natalie T, Fitzgerald, Paul, Glue, Paul, Sarma, Shanthi, Galvez-Ortiz, Veronica, Hadzi-Pavlovic, Dusan, Alonzo, Angelo, Dong, Vanessa, Martin, Donel, Nikolin, Stevan, Mitchell, Philip B, Berk, Michael, Carter, Gregory, Hackett, Maree, Leyden, John, Hood, Sean, Somogyi, Andrew A, Lapidus, Kyle, Stratton, Elizabeth, Gainsford, Kirsten, Garg, Deepak, Thornton, Nicollette L R, Fourrier, Célia, Richardson, Karyn, Rozakis, Demi, Scaria, Anish, Mihalopoulos, Cathrine, Chatterton, Mary Lou, McDonald, William M, Boyce, Philip, Holtzheimer, Paul E, Kozel, F Andrew, Riva-Posse, Patricio, Rodgers, Anthony

Get full text

Predictors of Change in Left-Ventricular Structure and Function in a Trial of Extended Hours Hemodialysis by Smyth, Brendan, Chan, Christopher T., Grieve, Stuart M., Puranik, Rajesh, Zuo, Li, Hong, Daqing, Gray, Nicholas A., De Zoysa, Janak R., Scaria, Anish, Gallagher, Martin, Perkovic, Vlado, Jardine, Meg

“…Myocardial pathology is common in patients undergoing hemodialysis. To explore the effects of differing aspects of dialysis treatment on its evolution, we…”
Get full text

Risk factors for incident kidney disease in older adults: an Australian prospective population‐based study by Kang, Amy, Sukkar, Louisa, Hockham, Carinna, Jun, Min, Young, Tamara, Scaria, Anish, Foote, Celine, Neuen, Brendon L., Cass, Alan, Pollock, Carol, Comino, Elizabeth, Lung, Thomas, Pecoits‐Filho, Roberto, Rogers, Kris, Jardine, Meg J.

“…Background and Aim To determine risk factors for incident chronic kidney disease (CKD) in a large population‐based cohort. Methods This prospective opt‐in…”
Get full text

Response to: Loutradis et al. Longer Dialysis Sessions Improve Cardiac Systolic Function by Reducing Myocardial Stunning by Smyth, Brendan, Chan, Christopher T, Grieve, Stuart M, Puranik, Rajesh, Zuo, Li, Hong, Daqing, Gray, Nicholas A, de Zoysa, Janak R, Scaria, Anish, Gallagher, Martin, Perkovic, Vlado, Jardine, Meg

Get full text

Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational study by Jun, Min, Scaria, Anish, Andrade, Jason, Badve, Sunil V, Birks, Peter, Bota, Sarah E, Campain, Anna, Djurdjev, Ognjenka, Garg, Amit X, Ha, Jeffrey, Harel, Ziv, Hemmelgarn, Brenda, Hockham, Carinna, James, Matthew T, Jardine, Meg J, Levin, Adeera, McArthur, Eric, Ravani, Pietro, Shao, Selena, Sood, Manish M, Tan, Zhi, Tangri, Navdeep, Whitlock, Reid, Gallagher, Martin

“…Abstract Aims The aim of this study was to determine the comparative effectiveness and safety of direct oral anticoagulants (DOACs) and warfarin in adults with…”
Get full text

A Randomized, Placebo-Controlled Trial of Pentoxifylline on Erythropoiesis-Stimulating Agent Hyporesponsiveness in Anemic Patients With CKD: The Handling Erythropoietin Resistance With Oxpentifylline (HERO) Trial by Johnson, David W., MBBS, DMed (Res), PhD, Pascoe, Elaine M., BSc, MBiostat, Badve, Sunil V., MBBS, MD, Dalziel, Kim, BHealthSc, MHealthEcon, PhD, Cass, Alan, MBBS, PhD, Clarke, Philip, BEc, MEc, PhD, Ferrari, Paolo, MD, McDonald, Stephen P., MBBS, PhD, Morrish, Alicia T., BSc, MPH, Pedagogos, Eugenie, MBBS, PhD, Perkovic, Vlado, MBBS, PhD, Reidlinger, Donna, BA, BAppSc, MPH, Scaria, Anish, BSc, MSc, Walker, Rowan, MD, MPH, Vergara, Liza A., MSc, PhD, Hawley, Carmel M., MBBS, MMedSci

“…Background Erythropoiesis-stimulating agent (ESA)-hyporesponsive anemia is common in chronic kidney disease (CKD). Pentoxifylline shows promise as a treatment…”
Get full text

Blood Eosinophils in Chinese COPD Participants and Response to Treatment with Combination Low-Dose Theophylline and Prednisone: A Post-Hoc Analysis of the TASCS Trial by Bradbury, Thomas, Di Tanna, Gian Luca, Scaria, Anish, Martin, Allison, Wen, Fu-Qiang, Zhong, Nan-Shan, Zheng, Jin-Ping, Barnes, Peter J, Celli, Bartolome, Berend, Norbert, Jenkins, Christine R

“…The burden of chronic obstructive pulmonary disease (COPD) disproportionately affects patients in low to middle-income countries. Although the Theophylline and…”
Get full text

Do Echocardiographic Parameters Predict Mortality in Patients With End-Stage Renal Disease? by Stallworthy, Elizabeth J, Pilmore, Helen L, Webster, Mark W.I, Sidhu, Karishma K, Curry, Elizabeth M, Brown, Pieta, Scaria, Anish

“…BACKGROUNDLeft ventricular function predicts cardiovascular mortality both in the general population and those with end-stage renal disease. Echocardiography…”
Get full text

Representativeness of Honeypot Trial Participants to Australasian PD Patients by Zhang, Lei, Badve, Sunil V., Pascoe, Elaine M., Beller, Elaine, Cass, Alan, Clark, Carolyn, de Zoysa, Janak, Isbel, Nicole M., Liu, Xusheng, McTaggart, Steven, Morrish, Alicia T., Playford, Geoffrey, Scaria, Anish, Snelling, Paul, Vergara, Liza A., Hawley, Carmel M., Johnson, David W.

“…Background The HONEYPOT trial failed to establish the superiority of exit-site application of Medihoney compared with nasal mupirocin prophylaxis for the…”
Get full text

The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial by Zhang, Lei, Badve, Sunil V, Pascoe, Elaine M, Beller, Elaine, Cass, Alan, Clark, Carolyn, de Zoysa, Janak, Isbel, Nicole M, McTaggart, Steven, Morrish, Alicia T, Playford, E Geoffrey, Scaria, Anish, Snelling, Paul, Vergara, Liza A, Hawley, Carmel M, Johnson, David W

“…♦ The HONEYPOT study recently reported that daily exit-site application of antibacterial honey was not superior to nasal mupirocin prophylaxis for preventing…”
Get full text